Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep;36(5):348-354.
doi: 10.1111/pcmr.13101. Epub 2023 Jun 9.

Trained immunity in the pathogenesis of vitiligo

Nicoline F Post  1 , Greta Ginski  1 , Rens Peters  1 , Nathalie O P Van Uden  1 , Marcel W Bekkenk  2 , Albert Wolkerstorfer  1 , Mihai G Netea  3 , Rosalie M Luiten  1
Affiliations
Review

Trained immunity in the pathogenesis of vitiligo

Nicoline F Post et al. Pigment Cell Melanoma Res. 2023 Sep.

Abstract

Vitiligo is caused by an autoimmune reaction against melanocytes leading to melanocyte loss. The cause of vitiligo is an interaction between genetic susceptibility and environmental factors. Both the adaptive immune system-through cytotoxic CD8+ T cells and melanocyte specific antibodies-and the innate immune system are involved in these immune processes in vitiligo. While recent data stressed the importance of innate immunity in vitiligo, the question remains why vitiligo patients' immune response becomes overly activated. Could a long-term increase in innate memory function, described as trained immunity after vaccination and in other inflammatory diseases, play a role as an enhancer and continuous trigger in the pathogenesis of vitiligo? After exposure to certain stimuli, innate immune system is able to show an enhanced immunological response to a secondary trigger, indicating a memory function of the innate immune system, a concept termed trained immunity. Trained immunity is regulated by epigenetic reprogramming, including histone chemical modifications and changes in chromatin accessibility that cause sustained changes in the transcription of specific genes. In responses to an infection, trained immunity is beneficial. However, there are indications of a pathogenic role of trained immunity in inflammatory and autoimmune diseases, with monocytes presenting features of a trained phenotype, resulting in increased cytokine production, altered cell metabolism through mTOR signaling, and epigenetic modifications. This hypothesis paper focusses on vitiligo studies that have shown these indications, suggesting the involvement of trained immunity in vitiligo. Future studies focusing on metabolic and epigenetic changes in innate immune cell populations in vitiligo could help in elucidating the potential role of trained immunity in vitiligo pathogenesis.

Keywords: innate immunity; pathogenesis; trained immunity; vitiligo.

PubMed Disclaimer

References

REFERENCES

    1. Aguennouz, M., Guarneri, F., Oteri, R., Polito, F., Giuffrida, R., & Cannavò, S. P. (2021). Serum levels of miRNA-21-5p in vitiligo patients and effects of miRNA-21-5p on SOX5, beta-catenin, CDK2 and MITF protein expression in normal human melanocytes. Journal of Dermatological Science, 101(1), 22-29.
    1. Ahn, Y., Seo, J., Lee, E. J., Kim, J. Y., Park, M. Y., Hwang, S., Almurayshid, A., Lim, B. J., Yu, J. W., & Oh, S. H. (2020). ATP-P2X7-induced inflammasome activation contributes to melanocyte death and CD8+ T-cell trafficking to the skin in vitiligo. Journal of Investigative Dermatology, 140(9), 1794-1804.e4.
    1. Arts, R. J. W., Carvalho, A., La Rocca, C., Palma, C., Rodrigues, F., Silvestre, R., Kleinnijenhuis, J., Lachmandas, E., Gonçalves, L. G., Belinha, A., Cunha, C., Oosting, M., Joosten, L. A. B., Matarese, G., van Crevel, R., & Netea, M. G. (2016). Immunometabolic pathways in BCG-induced trained immunity. Cell Reports, 17(10), 2562-2571.
    1. Arts, R. J. W., Joosten, L. A. B., & Netea, M. G. (2018). The potential role of trained immunity in autoimmune and autoinflammatory disorders. Frontiers in Immunology, 9, 298.
    1. Arts, R. J. W., Moorlag, S. J., Novakovic, B., Li, Y., Wang, S. Y., Oosting, M., Kumar, V., Xavier, R. J., Wijmenga, C., Joosten, L. A. B., Reusken, C. B. E. M., Benn, C. S., Aaby, P., Koopmans, M. P., Stunnenberg, H. G., van Crevel, R., & Netea, M. G. (2018). BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host & Microbe, 23(1), 89-100.